Related Experiment Video
Updated: Apr 1, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
Therapeutic Targeting of microRNAs in Cancer: Future Perspectives
Lütfi Tutar1, Esen Tutar2, Aykut Özgür3
1Faculty of Science and Letters, Department of Biology, Kahramanmaraş Sütçü İmam University, Kahramanmaraş, Turkey.
Abstract:
Preclinical Research The discovery of microRNAs (miRNAs) and their link with cancer has opened a new era in cancer therapeutics. Approximately, 18 - 24 nucleotides long, miRNAs can up-regulate or down-regulate gene expression in many cancer types and are respectively categorized as oncogenes (oncomirs) or tumor suppressors. Expression profiles of miRNAs with biomarker potential can be used for the classification, diagnosis, therapeutic treatment, and prognosis of different cancer types. miRNA mimics and miRNA antagonists are the two main approaches to miRNA-based cancer therapies that respectively inhibit oncomirs or restore the expression of tumor suppressive miRNAs. This review serves to provide some general insight into miRNA biogenesis, cancer related miRNAs, and miRNA therapeutics.
Insights
MicroRNAs (miRNAs) are key regulators in cancer, acting as oncogenes or tumor suppressors. miRNA-based therapies, using mimics or antagonists, offer new strategies for cancer treatment and diagnosis.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.
- Dysregulation of miRNAs is implicated in various cancer types, with roles as oncogenes (oncomirs) or tumor suppressors.
- miRNA expression profiles hold potential as biomarkers for cancer classification, diagnosis, and prognosis.
Purpose of the Study:
- To provide an overview of microRNA biogenesis.
- To discuss the role of specific miRNAs in cancer development and progression.
- To explore current and emerging miRNA-based therapeutic strategies for cancer.
Main Methods:
- Literature review of preclinical research on microRNAs in cancer.
- Analysis of miRNA biogenesis pathways.
- Examination of miRNA mimics and antagonists for therapeutic applications.
Main Results:
- miRNAs play a dual role in cancer, either promoting or suppressing tumor growth.
- miRNA expression patterns can serve as diagnostic and prognostic biomarkers.
- miRNA-based therapeutics aim to modulate miRNA activity to combat cancer.
Conclusions:
- MicroRNAs represent a significant area of research in oncology.
- Targeting miRNAs offers promising therapeutic avenues for cancer treatment.
- Further research into miRNA biogenesis and function will advance cancer care.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Microorganisms in Medicine and Therapeutics

